Research Frontiers Receives Nasdaq Delisting Notice for Bid Price and Market Value Deficiencies
Summary
Research Frontiers received two deficiency notices from Nasdaq for failing to meet the minimum bid price and market value of listed securities requirements, putting its Nasdaq listing at risk.
Key Events
-
Nasdaq Delisting Notice Received
Research Frontiers received two deficiency letters from Nasdaq on June 2, 2026, for non-compliance with continued listing rules.
-
Failed Minimum Bid Price Requirement
The company's common stock traded below the $1.00 minimum bid price for 30 consecutive business days.
-
Failed Minimum Market Value of Listed Securities (MVLS)
The company's MVLS fell below the $35 million minimum requirement for 30 consecutive business days.
-
Compliance Deadline Set
The company has 180 calendar days, until November 30, 2026, to regain compliance with both the bid price and MVLS requirements.
Analysis
This 8-K filing is critical as Research Frontiers faces potential delisting from Nasdaq due to its stock price falling below $1.00 and its market value of listed securities dropping below $35 million. The company has until November 30, 2026, to regain compliance. Given its recent Q1 revenue decline and net loss, and the fact it's trading near 52-week lows, achieving these targets without a reverse stock split presents a significant challenge. Failure to regain compliance could lead to the stock being moved to an over-the-counter market, which typically results in reduced liquidity and investor interest.
At the time of this filing, REFR was trading at $0.73 on NASDAQ in the Real Estate & Construction sector, with a market capitalization of approximately $25.7M. The 52-week trading range was $0.72 to $2.70. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.